UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.070

Sortiert nach

Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas

Journal of clinical oncology, 2014-01, Vol.32 (1), p.44-50

2014

Link zum Volltext

Verfügbarkeit prüfen

Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study

Journal of clinical oncology, 2016-04, Vol.34 (10), p.1104-1111

2016

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2011-05, Vol.29 (14), p.1803-1811

2011

Link zum Volltext

Verfügbarkeit prüfen

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group

Journal of clinical oncology, 2014-09, Vol.32 (27), p.3048-3058

2014

Link zum Volltext

Verfügbarkeit prüfen

False-Positive [18F]Fluorodeoxyglucose-Avid Lymph Nodes on Positron Emission Tomography–Computed Tomography After Allogeneic but Not Autologous Stem-Cell Transplantation in Patients With Lymphoma

Journal of clinical oncology, 2014-01, Vol.32 (1), p.51-56

2014

Link zum Volltext

Verfügbarkeit prüfen

Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2008-11, Vol.26 (32), p.5165-5169

2008

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Journal of clinical oncology, 2014-04, Vol.32 (11), p.1157-1163

2014

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

Journal of clinical oncology, 2016-08, Vol.34 (23), p.2698-2704

2016

Link zum Volltext

Verfügbarkeit prüfen

Protein Biomarker Identification in the CSF of Patients With CNS Lymphoma

Journal of clinical oncology, 2008-01, Vol.26 (1), p.96-105

2008

Link zum Volltext

Verfügbarkeit prüfen

Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Transformed Non-Hodgkin’s Lymphomas

Journal of clinical oncology, 2005-10, Vol.23 (30), p.7565-7573

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of a Transplantation Regimen of Yttrium-90 Ibritumomab Tiuxetan and High-Dose Chemotherapy in Patients With Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2008-01, Vol.26 (1), p.90-95

2008

Link zum Volltext

Verfügbarkeit prüfen

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

Journal of clinical oncology, 2014-03, Vol.32 (8), p.798-808

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcome of Lymphoma Patients After Idiotype Vaccination Is Correlated With Humoral Immune Response and Immunoglobulin G Fc Receptor Genotype

Journal of clinical oncology, 2004-12, Vol.22 (23), p.4717-4724

2004

Link zum Volltext

Verfügbarkeit prüfen

Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

Journal of clinical oncology, 2010-09, Vol.28 (27), p.4184-4190

2010

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma

Journal of clinical oncology, 2011-02, Vol.29 (6), p.690-697

2011

Link zum Volltext

Verfügbarkeit prüfen

Risk and Clinical Implications of Transformation of Follicular Lymphoma to Diffuse Large B-Cell Lymphoma

Journal of clinical oncology, 2007-06, Vol.25 (17), p.2426-2433

2007

Link zum Volltext

Verfügbarkeit prüfen

The Gray Zone Between Burkitt's Lymphoma and Diffuse Large B-Cell Lymphoma From a Genetics Perspective

Journal of clinical oncology, 2011-05, Vol.29 (14), p.1835-1843

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma

Journal of clinical oncology, 2011-03, Vol.29 (9), p.1198-1203

2011

Link zum Volltext

Verfügbarkeit prüfen

Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma

Journal of clinical oncology, 2002-05, Vol.20 (10), p.2453-2463

2002

Link zum Volltext

Verfügbarkeit prüfen

Accelerated Aging, Decreased White Matter Integrity, and Associated Neuropsychological Dysfunction 25 Years After Pediatric Lymphoid Malignancies

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3378-3388

2013

Link zum Volltext

Verfügbarkeit prüfen

Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors

Journal of clinical oncology, 2013-06, Vol.31 (16), p.1970-1976

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 3.070

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.070)
Mit Volltextzugriff
(3.070)

Publikationsform

Artikel
(3.070)

Sprache

Englisch
(3.070)
Japanisch
(590)
Russisch
(5)
Norwegisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(2.882)
Oncology
(2.693)
Life Sciences & Biomedicine
(2.661)
Science & Technology
(2.661)
Male
(2.031)
Female
(1.998)
Biological And Medical Sciences
(1.861)
Medical Sciences
(1.861)
Adult
(1.553)
Middle Aged
(1.548)
Hematologic And Hematopoietic Diseases
(1.377)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(1.365)
Aged
(1.199)
Tumors
(1.121)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(966)
Adolescent
(899)
Treatment Outcome
(828)
Prognosis
(691)
Child
(611)
Cancer Research
(580)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas

Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study

Pathogenesis of Non-Hodgkin's Lymphoma

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group

False-Positive [18F]Fluorodeoxyglucose-Avid Lymph Nodes on Positron Emission Tomography–Computed Tomography After Allogeneic but Not Autologous Stem-Cell Transplantation in Patients With Lymphoma

Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma

Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

Protein Biomarker Identification in the CSF of Patients With CNS Lymphoma

Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Transformed Non-Hodgkin’s Lymphomas

Phase II Trial of a Transplantation Regimen of Yttrium-90 Ibritumomab Tiuxetan and High-Dose Chemotherapy in Patients With Non-Hodgkin's Lymphoma

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial

Clinical Outcome of Lymphoma Patients After Idiotype Vaccination Is Correlated With Humoral Immune Response and Immunoglobulin G Fc Receptor Genotype

Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma

Risk and Clinical Implications of Transformation of Follicular Lymphoma to Diffuse Large B-Cell Lymphoma

The Gray Zone Between Burkitt's Lymphoma and Diffuse Large B-Cell Lymphoma From a Genetics Perspective

Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma

Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma

Accelerated Aging, Decreased White Matter Integrity, and Associated Neuropsychological Dysfunction 25 Years After Pediatric Lymphoid Malignancies

Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors

Aktive Filter

Suchergebnisse filtern